Thomson Reuters Positioned In The Leaders Quadrant in the Magic Quadrant for Enterprise Governance, Risk And Compliance Platforms

Recognized for completeness of vision and ability to execute for its Accelus Suite


LONDON - Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals, today announced it has been positioned by Gartner, Inc. in its Leaders Quadrant of the “Magic Quadrant for Enterprise Governance, Risk and Compliance Platforms” report published September 2, 2013.

Thomson Reuters Accelus is a leading suite of products which provide governance, risk and compliance (GRC) solutions to a broad range of regulated industries. In addition to the Enterprise GRC platform, the Accelus suite contains software and information solutions that provide specific content and functionality for board communications, financial reporting/disclosure compliance, regulatory intelligence, fraud screening, Anti-Money laundering and compliance training.

The Gartner Magic Quadrant for enterprise governance, risk and compliance (EGRC) platforms presents a global view of Gartner’s assessment of the main software vendors that should be considered by organizations seeking a technology solution to support the oversight and operation of enterprise-wide risk management and compliance programs, with the overall objective being improvements in corporate governance and the ability to achieve business objectives.

Thomson Reuters Accelus was placed in the Magic Quadrant after Gartner evaluated the Thomson Reuters Enterprise GRC solution on its ability to execute and its completeness of vision. Enterprise GRC is a comprehensive audit, internal controls management, policy management and compliance software solution purpose-built to address connected governance, risk and compliance requirements.

“We believe that our position in the ‘Leaders’ quadrant, as well as the report’s recognition of our ‘ability to execute’, reinforces our leadership and innovation in the GRC space,” says Andrew Neblett, managing director, Compliance, Audit & Risk, Thomson Reuters. “The world’s most complex companies trust the power of Thomson Reuters GRC solutions to transform how they manage their audit, risk management, and compliance processes and accelerate business growth. More and more, medium and large-sized enterprises are replacing legacy and point solution and turning to Thomson Reuters not only for our flexible, scalable enterprise GRC platform, but for compliance training, financial crime, and anti-bribery and corruption solutions.”

Thomson Reuters Governance, Risk & Compliance business dynamically connects business transactions, strategy and operations to the ever-changing regulatory environment, enabling firms to manage business risk. Thomson Reuters Accelus is a comprehensive suite of solutions specifically built to address the governance, risk and compliance challenges faced by the boardroom, and its legal, compliance, audit and risk management professionals.

Thomson Reuters
Thomson Reuters is the world’s leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world’s most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs approximately 60,000 people and operates in over 100 countries. Thomson Reuters shares are listed on the Toronto and New York Stock Exchanges. For more information, go to http://thomsonreuters.com.

Disclaimer:
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.